AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15871089 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of contrast material with percentage signal increase
Number of subjects: 45
Study 12866330 — intervention group
Group type: EXPERIMENTAL
Intervention: Audience Response System (ARS)
Number of subjects: 283
Study 12866330 — intervention group
Group type: COMPARATOR
Intervention: No Audience Response System (No ARS)
Number of subjects: 283
Study 10926659 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast incremental running (R) at 90% of VO(2 max)
Number of subjects: 17
Study 8721699 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight pigtail catheter with preset injection rate (Group IA, n = 46)
Number of subjects: 190
Study 8721699 — intervention group
Group type: EXPERIMENTAL
Intervention: Curved pigtail catheter with preset injection rate (Group IIA, n = 48)
Number of subjects: 190
Study 8721699 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight pigtail catheter with operator defined injection rate (Group IB, n = 49)
Number of subjects: 190
Study 8721699 — intervention group
Group type: EXPERIMENTAL
Intervention: Curved pigtail catheter with operator defined injection rate (Group IIB, n = 45)
Number of subjects: 190
Study 8721699 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall group analysis of 190 patients
Number of subjects: 190
Study 1416324 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium polystyrene sulfonate and sorbitol
Number of subjects: 0
Study 1416324 — intervention group
Group type: COMPARATOR
Intervention: Control (without sodium polystyrene sulfonate)
Number of subjects: 0
Study 4014145 — intervention group
Group type: EXPERIMENTAL
Intervention: Education program on diet, smoking, and exercise; personal counseling for high-risk workers.
Number of subjects: 1204
Study 4014145 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal counseling for high-risk workers.
Number of subjects: 1204
Study 31726194 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 4796
Study 31726194 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4796
Study 29516699 — intervention group
Group type: EXPERIMENTAL
Intervention: Thunder-fire moxibustion (Moxi) for 30 min, once a day for 14 days.
Number of subjects: 60
Study 29516699 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing (nursing) including health education.
Number of subjects: 60
Study 27716253 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-administered IVI
Number of subjects: 304
Study 27716253 — intervention group
Group type: COMPARATOR
Intervention: Physician-administered IVI
Number of subjects: 304
Study 25521472 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard counseling plus decision aid (DA)
Number of subjects: 104
Study 25521472 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling (SC) alone
Number of subjects: 104
Study 23835817 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate cancer screening module
Number of subjects: 118
Study 23835817 — intervention group
Group type: COMPARATOR
Intervention: Usual education about prostate cancer screening (Control)
Number of subjects: 118
Study 21183910 — intervention group
Group type: EXPERIMENTAL
Intervention: cytoflavin intravenously in dose 10 ml/day for 5 days
Number of subjects: 60
Study 21183910 — intervention group
Group type: COMPARATOR
Intervention: standard intensive therapy for burns
Number of subjects: 60
Study 17597254 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated provider posture
Number of subjects: 224
Study 17597254 — intervention group
Group type: COMPARATOR
Intervention: Standing provider posture
Number of subjects: 224
Study 17597254 — intervention group
Group type: EXPERIMENTAL
Intervention: Both seated and standing provider postures
Number of subjects: 224
Study 16616941 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital mobile phone exposure (DMP)
Number of subjects: 120
Study 16616941 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure to DMP
Number of subjects: 120
Study 12943490 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 0
Study 12943490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10990511 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX‐A)
Number of subjects: 52
Study 10990511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 8774297 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative media with < 1 pg/mL of endotoxin
Number of subjects: 100
Study 8774297 — intervention group
Group type: COMPARATOR
Intervention: Positive media with > or = 1 pg/mL of endotoxin
Number of subjects: 100
Study 8774297 — intervention group
Group type: EXPERIMENTAL
Intervention: Media with > 2 pg/mL of endotoxin
Number of subjects: 100
Study 1309477 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g citrus pectin added to a 500 kcal meal with 25 mg beta-carotene
Number of subjects: 7
Study 1309477 — intervention group
Group type: COMPARATOR
Intervention: Control meal (500 kcal) with 25 mg beta-carotene without pectin
Number of subjects: 7
Study 6368491 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional radiotherapy (RT) followed by weekly injection of vinblastine for 2 years
Number of subjects: 1059
Study 6368491 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenic irradiation
Number of subjects: 1059
Study 6368491 — intervention group
Group type: COMPARATOR
Intervention: Total nodal irradiation (TNI)
Number of subjects: 1059
Study 6368491 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + MOPP
Number of subjects: 1059
Study 6368491 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended RT (mantle + para‐aortic + spleen treatment)
Number of subjects: 1059
Study 6368491 — intervention group
Group type: EXPERIMENTAL
Intervention: TNI or combined modality treatment
Number of subjects: 1059
Study 30199273 — intervention group
Group type: EXPERIMENTAL
Intervention: Oculus Rift CV1
Number of subjects: 0
Study 30199273 — intervention group
Group type: COMPARATOR
Intervention: Oculus DK2
Number of subjects: 0
Study 30199273 — intervention group
Group type: EXPERIMENTAL
Intervention: Less sensory conflict games (e.g., third‐person platformer games, space and flight simulator games)
Number of subjects: 0
Study 30199273 — intervention group
Group type: EXPERIMENTAL
Intervention: VR games with a sense of spatial presence
Number of subjects: 0
Study 29384173 — intervention group
Group type: EXPERIMENTAL
Intervention: Catechin-enriched green tea (CEGT)
Number of subjects: 60
Study 29384173 — intervention group
Group type: EXPERIMENTAL
Intervention: Catechin-enriched oolong tea (CEOT)
Number of subjects: 60
Study 29384173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 27019421 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 30
Study 27019421 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30
Study 24971923 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal splint therapy for 30 days
Number of subjects: 65
Study 24971923 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 65
Study 22339322 — intervention group
Group type: EXPERIMENTAL
Intervention: Media Ready Program
Number of subjects: 412
Study 22339322 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 412
Study 20850054 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to thin fashion models
Number of subjects: 64
Study 20850054 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to heavier ('plus-sized') models
Number of subjects: 64
Study 20850054 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to idealizing images
Number of subjects: 64
Study 16952975 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 7599
Study 16952975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7599
Study 15689962 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan (TRP) depletion (ATD)
Number of subjects: 12
Study 15689962 — intervention group
Group type: COMPARATOR
Intervention: Balanced amino-acid drink (placebo)
Number of subjects: 12
Study 12165588 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding promotion intervention modeled on the WHO/UNICEF Baby-Friendly Hospital Initiative
Number of subjects: 17046
Study 12165588 — intervention group
Group type: COMPARATOR
Intervention: Control group (then current infant feeding practices)
Number of subjects: 17046
Study 12165588 — intervention group
Group type: COMPARATOR
Intervention: Observational analysis of infants weaned in the first month
Number of subjects: 17046
Study 12165588 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged and exclusive breastfeeding groups
Number of subjects: 17046
Study 10432134 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical estradiol (E2) cream and pelvic muscle biofeedback training
Number of subjects: 39
Study 10432134 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream and pelvic muscle biofeedback training
Number of subjects: 39
Study 10432134 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical estradiol (E2) cream and sham biofeedback
Number of subjects: 39
Study 10432134 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream and sham biofeedback
Number of subjects: 39
Study 7576966 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-PCR detection of tyrosine hydroxylase (TH) mRNA
Number of subjects: 0
Study 1844356 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical mechlorethamine hydrochloride in aqueous vehicle
Number of subjects: 6
Study 1844356 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical mechlorethamine hydrochloride in ointment vehicle
Number of subjects: 6
Study 1844356 — intervention group
Group type: COMPARATOR
Intervention: Environmental examination for contamination
Number of subjects: 6
Study 6406452 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 0
Study 6406452 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0
Study 30080424 — intervention group
Group type: EXPERIMENTAL
Intervention: Load-Velocity Profile (LVP)
Number of subjects: 15
Study 30080424 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed Sets 20% Velocity Loss Threshold (FSVL20)
Number of subjects: 15
Study 30080424 — intervention group
Group type: COMPARATOR
Intervention: Traditional 1RM-Percent-Based Training (PBT)
Number of subjects: 15
Study 29658370 — intervention group
Group type: EXPERIMENTAL
Intervention: High flavanol high theobromine (HFHT) chocolate
Number of subjects: 131
Study 29658370 — intervention group
Group type: COMPARATOR
Intervention: Low flavanol and theobromine chocolate (LFLT)
Number of subjects: 131
Study 29658370 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic HFHT intake
Number of subjects: 131
Study 27043141 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual n-back working memory training
Number of subjects: 57
Study 27043141 — intervention group
Group type: COMPARATOR
Intervention: Active control (processing speed training)
Number of subjects: 57
Study 24449682 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (1 mg) via mucosal atomization device (MAD) twice a day for 60 days
Number of subjects: 20
Study 24449682 — intervention group
Group type: COMPARATOR
Intervention: Budesonide via impregnated nasal saline irrigation (INSI) twice a day for 60 days
Number of subjects: 20
Study 21367551 — intervention group
Group type: EXPERIMENTAL
Intervention: CT arthrography
Number of subjects: 36
Study 21367551 — intervention group
Group type: EXPERIMENTAL
Intervention: MR arthrography
Number of subjects: 36
Study 20305852 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental ceramic suitable for titanium and zirconia frameworks (TEC: 8.5 microm/m*K)
Number of subjects: 75
Study 20305852 — intervention group
Group type: COMPARATOR
Intervention: Commercially available low-fusing ceramic optimized for zirconia frameworks (TEC: 9.5 microm/m*K)
Number of subjects: 75
Study 17571283 — intervention group
Group type: EXPERIMENTAL
Intervention: Advicor (1000/20 mg)
Number of subjects: 40
Study 17571283 — intervention group
Group type: COMPARATOR
Intervention: Niacin ER (1000 mg)
Number of subjects: 40
Study 17571283 — intervention group
Group type: COMPARATOR
Intervention: Lovastatin (20 mg)
Number of subjects: 40
Study 17571283 — intervention group
Group type: COMPARATOR
Intervention: Niacin ER (1000 mg) + Lovastatin (20 mg)
Number of subjects: 40
Study 16392205 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous suture technique
Number of subjects: 100
Study 16392205 — intervention group
Group type: COMPARATOR
Intervention: Intracutaneous suture technique
Number of subjects: 100
Study 12057883 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy
Number of subjects: 1558
Study 12057883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1558
Study 10743483 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate breakfast with red pepper (10 g)
Number of subjects: 23
Study 10743483 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed diet with red-pepper appetizer (6 g)
Number of subjects: 23
Study 10743483 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate breakfast
Number of subjects: 23
Study 10743483 — intervention group
Group type: COMPARATOR
Intervention: Mixed diet without red-pepper appetizer
Number of subjects: 23
Study 8535554 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA, aspirin) 75 mg daily
Number of subjects: 19193
Study 8535554 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonist, felodipine, 5 mg once daily
Number of subjects: 19193
Study 2191582 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg isosorbide‐5‐mononitrate (IS‐5‐MN) in sustained-release (SR) form
Number of subjects: 18
Study 2191582 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg isosorbide‐5‐mononitrate (IS‐5‐MN) in sustained-release (SR) form
Number of subjects: 18
Study 2191582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6999981 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ampicillin (150 mg/kg per day)
Number of subjects: 96
Study 6999981 — intervention group
Group type: COMPARATOR
Intervention: Low-dose ampicillin (50 mg/kg per day)
Number of subjects: 96
Study 29139311 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity physical activity integrated with standard smoking cessation intervention
Number of subjects: 0
Study 29139311 — intervention group
Group type: COMPARATOR
Intervention: Standard care cessation only
Number of subjects: 0
Study 28716046 — intervention group
Group type: EXPERIMENTAL
Intervention: UTR (Fresenius)
Number of subjects: 50
Study 28716046 — intervention group
Group type: COMPARATOR
Intervention: CONV (Conventional dialysis)
Number of subjects: 50
Study 28716046 — intervention group
Group type: EXPERIMENTAL
Intervention: UCR (Nikkiso)
Number of subjects: 50
Study 28716046 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 50
Study 25645425 — intervention group
Group type: COMPARATOR
Intervention: Successful weight losers (SWL)
Number of subjects: 34
Study 25645425 — intervention group
Group type: COMPARATOR
Intervention: Overweight (OW) individuals
Number of subjects: 34
Study 24485005 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision-training educational intervention
Number of subjects: 154
Study 24485005 — intervention group
Group type: COMPARATOR
Intervention: Control group (instructions only)
Number of subjects: 154
Study 22989763 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritonsillar infiltration of tramadol
Number of subjects: 60
Study 22989763 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritonsillar infiltration of lidocaine
Number of subjects: 60
Study 22989763 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 60
Study 20524462 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium infusion (10 mmol of magnesium sulphate dissolved in 100 ml of saline solution infused intravenously over 4 hours, for 3 days)
Number of subjects: 220
Study 20524462 — intervention group
Group type: COMPARATOR
Intervention: Control group (no magnesium infusion)
Number of subjects: 220
Study 20524462 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium infusion
Number of subjects: 220
Study 17496236 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone patch (5 mg/day) for 2 years
Number of subjects: 55
Study 17496236 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 years
Number of subjects: 55
Study 15383046 — intervention group
Group type: EXPERIMENTAL
Intervention: Left auricular reduction and mitral surgery (Group I)
Number of subjects: 50
Study 15383046 — intervention group
Group type: COMPARATOR
Intervention: Isolated valve surgery (Group II)
Number of subjects: 50
Study 11479456 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 970
Study 11479456 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressively dosed statin (simvastatin)
Number of subjects: 970
Study 11479456 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite of all-cause mortality, myocardial infarction (MI), and documented refractory ischemia at 7 days
Number of subjects: 970
Study 11479456 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite of cardiovascular death, MI, readmission for ACS, and stroke
Number of subjects: 970
Study 10023277 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 20
Study 10023277 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional endoscopy)
Number of subjects: 20
Study 7833098 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron 0.20 mg/kg or more
Number of subjects: 44
Study 7833098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 2971708 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled VIP (70 micrograms)
Number of subjects: 6
Study 2971708 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (40 micrograms)
Number of subjects: 6
Study 2971708 — intervention group
Group type: EXPERIMENTAL
Intervention: Both VIP and Ipratropium bromide
Number of subjects: 6
Study 2971708 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (provocative dose)
Number of subjects: 6
Study 30314505 — intervention group
Group type: EXPERIMENTAL
Intervention: Stand Up intervention (strategies to reduce prolonged sitting)
Number of subjects: 134
Study 30314505 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit Less intervention (strategies to reduce total sitting time)
Number of subjects: 134
Study 30314505 — intervention group
Group type: EXPERIMENTAL
Intervention: Move More intervention (strategies to increase purposeful walking)
Number of subjects: 134
Study 28232410 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (7%)
Number of subjects: 22
Study 28232410 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (0.9%)
Number of subjects: 22
Study 25741158 — intervention group
Group type: EXPERIMENTAL
Intervention: Pronase and simethicone (Group A)
Number of subjects: 143
Study 25741158 — intervention group
Group type: COMPARATOR
Intervention: Simethicone alone (Group B)
Number of subjects: 143
Study 24019429 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based water treatment, hygiene, and sanitation program
Number of subjects: 40
Study 24019429 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 21398389 — intervention group
Group type: EXPERIMENTAL
Intervention: Home telerehabilitation (16 sessions over two months conducted by trained physiotherapists via videoconferencing)
Number of subjects: 48
Study 21398389 — intervention group
Group type: COMPARATOR
Intervention: Usual care (conventional rehabilitation)
Number of subjects: 48
Study 19608353 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial treatments for marijuana dependence
Number of subjects: 207
Study 16497840 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal treadmill exercise tests
Number of subjects: 100
Study 14509461 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ketorolac 0.5%
Number of subjects: 36
Study 14509461 — intervention group
Group type: COMPARATOR
Intervention: Control group (no topical ketorolac)
Number of subjects: 36
Study 11153592 — intervention group
Group type: EXPERIMENTAL
Intervention: auto-CPAP treatment
Number of subjects: 18
Study 11153592 — intervention group
Group type: COMPARATOR
Intervention: conventional CPAP treatment
Number of subjects: 18
Study 9390478 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral hygiene with 1100-ppm fluoride toothpaste and 2% NaF treatment
Number of subjects: 18
Study 9390478 — intervention group
Group type: COMPARATOR
Intervention: Control group without cleaning
Number of subjects: 18
Study 1493344 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen (50 micrograms in 1 ml preservative-free normal saline)
Number of subjects: 9
Study 2944435 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine-diazepam anaesthesia
Number of subjects: 127
Study 28379526 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal instruments
Number of subjects: 0
Study 28379526 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-causal instruments
Number of subjects: 0
Study 26758438 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated fish oil
Number of subjects: 0
Study 26758438 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated fish oil and evening primrose oil
Number of subjects: 0
Study 26758438 — intervention group
Group type: COMPARATOR
Intervention: Regular rheumatologic therapy (Control)
Number of subjects: 0
Study 24766981 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased levels of C-reactive protein (CRP)
Number of subjects: 2945
Study 24766981 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased levels of fibrinogen
Number of subjects: 2945
Study 24766981 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased levels of white blood cells (WBC)
Number of subjects: 2945
Study 24766981 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined 'inflammation score'
Number of subjects: 2945
Study 24766981 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediation by myocardial infarction (MI)
Number of subjects: 2945
Study 21883301 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading physical aggression story
Number of subjects: 0
Study 21883301 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading relational aggression story
Number of subjects: 0